WT | News

Discover our incredible news!

News

X
Text dummy
Text Link

5 Predictions for Digital Healthcare in 2021

In 2020, the world witnessed in disbelief how a virus shut down the world. As the COVID-19...

In 2020, the world witnessed in disbelief how a virus shut down the world. As the COVID-19 pandemic swept through nations, it paralyzed healthcare systems across the globe, prompting calls to adopt digital health. COVID-19 changed everything about healthcare delivery in 2020 and experts say we’ll see more disruptions of the status quo and acceleration of virtual care adoptions.

Read more: How COVID-19 Pandemic Is Accelerating Digital Health with No Signs of Downtrend

Here are 5 predictions for healthcare in 2021:

  1. Remote patient care and telemedicine

The pandemic has increased the popularity of telemedicine as people around the globe chose to maintain social distance. This has proved that remote consultations are not only possible, but these practices are easy to achieve and preferred by many. In 2021, telemedicine and remote patient monitoring will continue to thrive. According to MarketsAndMarkets report, the global telehealth and telemedicine market is expected to grow at a CAGR of 37.7% during the forecast period, to reach USD 191.7 billion by 2025 from an estimated USD 38.7 billion in 2020.

  1. Virtual Reality

According to a report by Research and Markets, the global VR market was valued at USD 3.13 billion in 2017 and is expected to reach USD 49.7 billion by 2023, at a CAGR of 58.54% over the forecast period (2018-2023). With big companies such as Sony and HTC entering, and technological advancements in VR are expected to generate a plethora of VR solutions with diverse capabilities, which allow consumers to experience utmost immersion.

  1. Wearables

Self-monitoring applications come in many forms, but one that’s seeing promising returns is wearable devices, a market that’s expected to reach more than $27 million in 2023, up from $8 million in 2017, reports TheNextWeb. The wearable devices market is empowering people to take charge of their own healthcare. 2021 will be the year where wearables will make a giant leap with devices that monitor blood Oxygen saturation, heart rate, social distancing, and more.

  1. Artificial Intelligence

Artificial Intelligence (AI) is impacting the healthcare industry greatly and in 2021 AI will play a huge role in the digital transformation of healthcare. According to MarketsAndMarkets, the global AI in healthcare market size is expected to grow from USD 4.9 billion in 2020 and reach USD 45.2 billion by 2026; it is projected to grow at a CAGR of 44.9% during the forecast period. The major factors driving the market growth are the increasing volume of healthcare data and growing complexities of datasets driving the need for AI, the intensifying need to reduce towering healthcare costs, improving computing power and declining hardware costs, a growing number of cross-industry partnerships and collaborations, and rising imbalance between health workforce and patients driving the need for improvised healthcare services.

Read more: Global Medical Wearables Market Size to Reach US $85.6 Billion by 2027

  1. Advancements in EHR

The federal government has passed new regulations that aim to help patients gain better control of their health data via smartphone apps, interoperability is expected to increase between providers, payers and health tech developers. One of the most advantageous features involved with electronic health records is security. In the new year, more advanced EHR systems will help the healthcare industry maintain privacy and security of patient data.

Text Link

Lenovo Launches ThinkReality A3 – Advanced and Versatile Smart Glasses at the CES 2021

Today, at the virtual Consumer Electronics Show (CES 2021), Lenovo introduced the ThinkReality A3...

Today, at the virtual Consumer Electronics Show (CES 2021), Lenovo introduced the ThinkReality A3 lightweight smart glasses. One of the most advanced and versatile enterprise smart glasses to come to market, the ThinkReality A3 is part of comprehensive digital solutions offering to deliver intelligent transformation in business and bring smarter technology to more people.

Read more: Vuzix Smart Glasses Combined With Topcon’s MAGNET Software Boost Efficiency In Construction Sites

As increasingly distributed workforces and hybrid work models become the reality of a new normal, small and large businesses around the world are looking to adopt new technologies for smart collaboration, increased efficiency, and lower downtimes. From customized virtual monitors and 3D visualization to Augmented Reality (AR) assisted workflows and immersive training, the ThinkReality A3 helps transforms work across many levels of the enterprise, reports BusinessWire.

ThinkReality PC Edition

The ThinkReality A3 PC Edition tethers to a laptop or mobile workstation to enable users to position multiple, large virtual monitors in their field of view and use Windows software tools and applications. Virtual monitors expand the value of PCs, creating more productivity, privacy, and immersive experiences.

The ThinkReality A3 Industrial Edition

The ThinkReality A3 Industrial Edition tethers to select Motorola smartphones1 for hands-free, AR-supported tasks in complex work environments. The Industrial Edition is supported by the ThinkReality software platform, which enables commercial customers to build, deploy, and manage mixed reality applications and content on a global scale, with global support.

ThinkReality Ecosystem of AR/VR Solutions

Lenovo’s ThinkReality platform is helping accelerate the adoption of the next generation of wearable computing — offering smarter technology to enable smarter workers. With the growing ThinkReality cloud-agnostic ecosystem of hardware and software solutions, enterprises have more choices in building and deploying mixed reality technologies to improve business.

“The A3 is a next-generation augmented reality solution – light, powerful and versatile. The smart glasses are part of a comprehensive integrated digital solution from Lenovo that includes the advanced AR device, ThinkReality software, and Motorola mobile phones. Whether working in virtual spaces or supporting remote assistance, the ThinkReality A3 enhances workers’ abilities to do more wherever they are,” said Jon Pershke, Lenovo Vice President of Strategy and Emerging Business, Intelligent Device Group.

Read more: Plessey and WaveOptics Partner Up for MicroLED Display Technology for Smart Glasses

Availability

The Lenovo ThinkReality A3 smart glasses will be available in select markets worldwide starting mid-2021. Visit the ThinkReality A3 web page to find out more, or contact your local Lenovo sales representative.

Text Link

Stryker Buys OrthoSensor and Its Knee Surgery Sensor Technology Verasense

Stryker said it has acquired OrthoSensor and its Verasense intraoperative sensor technology...

Stryker said it has acquired OrthoSensor and its Verasense intraoperative sensor technology. OrthoSensor is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. The acquisition could help Stryker enhance its Mako robots. Financial terms of the deal were not disclosed.

Read more: OrthoSensor and McLaren Applied Starts New Venture to Improve Wearable Sensors in Orthopedic Procedures

Stryker said that Verasense since 2011 has proved itself to be a unique knee balancing solution in Stryker’s Triathlon knee system, providing feedback to surgeons on soft tissue. The company believes that the Verasense sensor tech will further boost its Mako surgical robotics systems, enhancing workflow through one complete data-driven feedback mechanism.

“Smart devices and implants will play a big role in orthopedics and we are excited for OrthoSensor to join Stryker as we continue to innovate and advance smart sensor technologies, including intraoperative sensors, wearables, and smart implants across our joint replacement business,” said Spencer Stiles, Stryker’s Group President, Orthopedics and Spine. “Patient recovery will become more active as real-time measurement on key performance insights drives improved outcomes and patient satisfaction.”

OrthoSensor quantifies orthopedics through intelligent devices and data services that allow surgeons and hospitals to deliver evidence-based treatments for all healthcare stakeholders. The company’s advancements in sensor technology, coupled with expanded data analytics and increasing computational power, will strengthen the foundation of Stryker’s digital ecosystem, reports GlobeNewsWire.

With technologies spanning the continuum of care, the acquisition of OrthoSensor allows Stryker to empower surgeons with comprehensive data-driven solutions. OrthoSensor’s market-leading VERASENSE™ intraoperative sensor creates a unique knee balancing solution and has been used with Stryker’s Triathlon® Knee System since 2011.

Read more: Pixee Medical Successfully Finishes its First Total Knee Replacement Surgery Guided Only by the Vuzix M400 AR Glasses

Complementary to Stryker’s category-leading Mako SmartRobotics™, this technology will enhance the robotic workflow through one complete data-driven feedback mechanism. Additionally, the MotionSense™ remote patient monitoring wearables and mobile application combined with the OrthloLogIQ® cloud-based data platform further enhance Stryker’s insightful data analytics capabilities.

Text Link

Mind Cure Releases iSTRYM: A Digital Platform for Mental Health and Psychedelic Research

Canadian mental health firm Mind Cure has released a digital therapeutic tool designed to close...

Canadian mental health firm Mind Cure has released a digital therapeutic tool designed to close the gaps between patients, clinicians and researchers. The app, called iSTRYM, has been designed to warehouse the largest collection of psychedelic research and ongoing mental optimization data. With machine learning deployed, iSTRYM will provide greater speed to Mind Cure's research team, richer data to health professionals and clients, as well as a hub of protocol and procedural information for psychedelic practitioners worldwide.

Related: Swedish Startup Flow Launches Mental Health Chatbot to Combat Depression

“As a life sciences and digital therapeutics company, providing speed to market with novel psychedelic therapies through deeper data analytics is a strength we are developing with iSTRYM,” says Kelsey Ramsden, President & CEO. “Further, as we build out our database for mental wellness, both therapists and individuals will get mental wellness protocols for wellness optimization and support. iSTRYM exists to become the source that individuals turn to for science-backed, personalized mental health support at scale.”

Gaps between clients, researchers, and therapists create disparities in the collection of critical insights that arise outside of psychedelic-assisted therapy sessions, and ultimately prevent new scientific breakthroughs. Mind Cure's iSTRYM provides a digital solution to the loss of crucial, uncategorized data points by connecting patient feedback and clinician expertise together in one place. Additionally, most psychedelic therapy research exists in cloistered scientific communities, which limits the possible intersection of great clinical practice and new protocols. iSTRYM brings together a large database of existing protocols to all psychedelic clinicians, enhancing the scientific efficacy for the entire psychedelic research community, Mind Cure said in a press release.

“We're developing the kind of global administration portal that could become the solution the industry needs. One of the key differentiators in our proprietary tech piece is the implementation of artificial intelligence, working in the background, to taxonify the uncategorized daily inputs from patients into tangible assets that will then inform treatments. From onboarding patients to collecting critical insights across different arms of the psychedelics research space, iSTRYM could revolutionize the way we build communities around a common goal of mental wellness,” said Mind Cure CTO Geoff Belair.

Related: Feel: A Digital Therapeutic Solution for Mental Health

iSTRYM is a centralized management system for psychedelic therapeutic research, the deployment of care and integration based on a microservices design model, and is built with responsive principals. iSTRYM contains strategic data loops that continually aggregate new insights, and an application that equips patients as active participants in their own mental wellness journey.

Text Link

BIOTRONIK Wins FDA Clearance for its Vital Data Sensor in BIOMONITOR IIIm ICM

German biomedical company BIOTRONIK has won FDA clearance for the Vital Data Sensor, a body temp...

German biomedical company BIOTRONIK has won FDA clearance for the Vital Data Sensor, a body temperature component within the BIOMONITOR IIIm injectable cardiac monitor (ICM).

Read more: BIOTRONIK Receives FDA Approval for Six Tachycardia Devices

Physicians will now have access to daily reports on vital data, including body temperature, and cardiac arrhythmia data to help them monitor patient health and their treatment remotely. BIOMONITOR IIIm contains integrated sensor technologies designed to measure patient activity, heart rate and body temperature. The interrelationship between these vital signs and health conditions is well-documented, particularly fever, which leads to increases in mean and resting heart rates and possible decreases in activity levels, reports Biotronik.

The first US case using BIOMONITOR IIIm was performed by Dr. Luigi Di Biase. “The patient is at high risk for infection during this global pandemic due to underlying conditions. It is comforting for me and my patients knowing that we will be able to monitor for early signs of potential life-threatening cardiac arrhythmias and infections for up to 5.5 years. Coupled with the workflow advantages, this device is a step forward for injectable cardiac monitors,” said Di Biase, section head of Electrophysiology, Director of Arrhythmia Services at Montefiore Health System.

This exclusive integrated sensor in BIOMONITOR IIIm enables physicians to stay connected with cardiac patients and proactively monitor them for warning signs at home - preserving capacity in hospitals for the sickest patients. This meaningful digital health innovation can potentially provide earlier detection while helping to streamline remote patient management.

“Vital data trends help support the diagnosis for a range of illnesses and, given the additional impact of the current pandemic on cardiac health, we have worked with urgency to advance BIOMONITOR IIIm’s unique sensor technology,” said Dr. David Hayes, Chief Medical Officer of BIOTRONIK Inc. “Patients with cardiac conditions are at an increased risk for worse outcomes from many systemic illnesses, so closer monitoring of these patients may help manage potential symptoms associated with a febrile response, particularly if it can be done safely and remotely.”

Read more: Abbott’s Confirm Rx Smartphone Compatible ICM Offers More Accurate Detection of Arrhythmia

In addition to these benefits, BIOMONITOR IIIm is the industry leader in battery longevity with 5.5 years of continuous monitoring, providing long-term monitoring of chronic cardiac conditions. BIOMONITOR devices have a unique design that facilitates a one-step injection procedure, delivers class-leading detection performance and signal fidelity comparable to gold-standard 12-lead ECG recordings. In addition, the proven performance of BIOTRONIK Home Monitoring ensures 98 percent daily transmission success for streamlined clinical device management.

Text Link

This AI-Powered Sensor Recognizes Hand Gestures, Have Potential Use in Prosthetics

Researchers at the University of California, Berkeley have developed a wearable sensor that...

Researchers at the University of California, Berkeley have developed a wearable sensor that combines artificial intelligence (AI) software to help recognize what hand gesture a person intends to make based on electrical signal patterns in the forearm. The device could one day be used to control prosthetics or to interact with almost any type of electronic device.

Read more: NUS Scientists Develop Electronic Skin with Exceptional Sense of Touch for Prosthetics

“Prosthetics are one important application of this technology, but besides that, it also offers a very intuitive way of communicating with computers.” said Ali Moin, who helped design the device as a doctoral student in UC Berkeley’s Department of Electrical Engineering and Computer Sciences. “Reading hand gestures is one way of improving human-computer interaction. And, while there are other ways of doing that, by, for instance, using cameras and computer vision, this is a good solution that also maintains an individual’s privacy.”

Moin is co-first author of a new paper describing the device, which appears online in the journal Nature Electronics.

The research team has demonstrated that the hand gesture recognition system can classify up to 21 different hand signals, including a thumbs-up, a fist, a flat hand, holding up individual fingers and counting numbers, reports Kara Manke in Berkeley News.

To create the hand gesture recognition system, the team collaborated with Ana Arias, a professor of electrical engineering at UC Berkeley, to design a flexible armband that can read the electrical signals at 64 different points on the forearm. The electrical signals are then fed into an electrical chip, which is programmed with an AI algorithm capable of associating these signal patterns in the forearm with specific hand gestures.

The team succeeded in teaching the algorithm to recognize 21 individual hand gestures, including a thumbs-up, a fist, a flat hand, holding up individual fingers and counting numbers.

“When you want your hand muscles to contract, your brain sends electrical signals through neurons in your neck and shoulders to muscle fibers in your arms and hands,” Moin said. “Essentially, what the electrodes in the cuff are sensing is this electrical field. It’s not that precise, in the sense that we can’t pinpoint which exact fibers were triggered, but with the high density of electrodes, it can still learn to recognize certain patterns.”

Like other AI software, the algorithm has to first “learn” how electrical signals in the arm correspond with individual hand gestures. To do this, each user has to wear the cuff while making the hand gestures one by one.

However, the new device uses a type of advanced AI called a hyperdimensional computing algorithm, which is capable of updating itself with new information.

For instance, if the electrical signals associated with a specific hand gesture change because a user’s arm gets sweaty, or they raise their arm above their head, the algorithm can incorporate this new information into its model.

Another advantage of the new device is that all of the computing occurs locally on the chip: No personal data are transmitted to a nearby computer or device. Not only does this speed up the computing time, but it also ensures that personal biological data remain private, UC Berkeley reported.

The device is not ready to be a commercial product yet. But it could likely get there with a few tweaks, according to Jan Rabaey, the Donald O. Pedersen Distinguished Professor of Electrical Engineering at UC Berkeley and senior author of the paper.

Read more: Electronic Skin for Prosthetic Hands Lets Amputees Feel Pain

“Most of these technologies already exist elsewhere, but what’s unique about this device is that it integrates the biosensing, signal processing and interpretation, and artificial intelligence into one system that is relatively small and flexible and has a low power budget,” Rabaey said.

Text Link

Oscar Closes $140M New Funding Round, Led By Tiger Global Management

Oscar Health, a New York City-based health insurance technology company, has raised $140 million...

Oscar Health, a New York City-based health insurance technology company, has raised $140 million in a funding round announced just six months after its last $225 million raise. The round was led by Tiger Global Management, LLC, with participation from Dragoneer, Baillie Gifford, Coatue, Founders Fund, Khosla, Lakestar and Reinvent. The financing comes as Oscar continues to experience significant growth, seeing a 74% increase in direct policy premiums over the past three years.

Read more: Cardiogram Signs Deal with Oscar Health to Allow Members Free Wearable-Based Monitoring

“Since 2017, Oscar has seen annualized membership growth of more than 70%,” said Mario Schlosser, Co-Founder, and CEO of Oscar. “As we continue to rapidly scale our business, this capital will help us deliver on our commitment to bring accessible and affordable care to even more Oscar members across the country.”

The announcement takes place as Open Enrollment for 2021 closes for much of the U.S. Heading into the new year, Oscar will be available in 18 states and 286 counties across its Individual and Family Plans, Medicare Advantage and Small group products. As of September 30, 2020, Oscar had approximately 420,000 members across 15 states, Oscar Health said in a press release.

Oscar launched in 2012 with the intention of transforming how people interact with their health insurance company. Since then, the company has seen significant growth driven by its industry-leading levels of member engagement. Oscar members have mobile app downloads that are approximately nine times the average of other insurers. 88% of subscribing members have interacted with Oscar digitally. This engagement allows Oscar to get to know its members better and intervene to shift behavior in the direction of healthier and more affordable options.

The combination of Oscar's member engagement engine and full-stack technology platform allows the insurer to help its members find high-quality care. 48% of first-time PCP visits for Oscar members are with an Oscar recommended doctor. Additionally, since 2014, all of its members have had 24/7 access to Oscar's virtual care offerings, in nearly all cases at no additional cost. Of the subscribing members who have had one or more medical visits, 38% have used Oscar's virtual care offering.

Oscar's member engagement model results in high levels of member trust and satisfaction, too, with 68% of surveyed members stating that they trust Oscar to give them advice on how and where to get the care they need. Oscar's Net Promoter Score is 30, compared with the average negative 4 among other health insurers.

Read more: Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion

Oscar is the first health insurance company built around a full-stack technology platform and a relentless focus on serving its members. The company's member-first philosophy and innovative approach to care has earned us the trust of more than 420,000 Americans across 211 counties.

Text Link

Bold Health Cognitive Behavior Therapy App for IBS

London-based Bold Health is developing a CBT app for IBS, being tested against Headspace in a study.

London-based digital health company Bold Health is developing digital therapeutics for gastrointestinal conditions. The company is backing a new University of Pennsylvania-led study that will directly compare the company’s cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace’s consumer mindfulness and meditation app, reports MobiHealthNews.

Researchers will be randomly assigning 300 participants with IBS to receive either Bold Health’s Zemedy app or the Headspace mindfulness app for free. Each group will have the app for eight weeks, after which those who received the Headspace app will also be given access to Zemedy.

Read more Sanofi and Babylon Team Up to Tackle Digestive Health Issues

Chronic digestive problems are common and often connected to poor mental wellbeing. Through Bold Health’s digital applications, patients get access to cognitive behavioral therapy (CBT) programs designed for their specific condition.

Zemedy’s 6-week program is designed around core cognitive behavioral therapy (CBT) principles. IBS symptoms are often exacerbated due to stress and anxiety.

The aim of the Zemedy program is to help users target symptoms and difficult emotions by changing the surrounding thoughts and behaviors. Users can practice these techniques in their own safe spaces and learn how to manage their symptoms in the long term.

Depiction of a person suffering from Irritable Bowel Syndrome (IBS). The typical symptoms of IBS have been shown. Also, an abnormal colon contraction has been. (Image: Myupchar, Wikimedia Commons)

After eight weeks of the trial, the researchers will administer a battery of questionnaires, and those who switched from Headspace to Zemedy will receive a third slew of questions after an additional eight weeks with Bold Health’s app, the MobiHealthNews report said.

Through these surveys, the researchers will be comparing responses regarding the study’s primary outcomes: IBS quality of life, and the severity of their gastrointestinal symptoms. Secondary outcomes include respondents’ scores on various gastrointestinal-related measurements, including their anxiety regarding visceral gut sensations, fear of food or eating, and impairments to their work due to health conditions.

Read more Oshi Health Launches First All-in-One Mobile App to Allow IBD Patients Manage Their Conditions

With this new trial, Bold Health is making the case that Zemedy, which is branded as a digital therapeutic, will be demonstrably more effective than a corresponding consumer wellness app.

Text Link

Diameter Health Secures $18M in Series B Funding To Improve Health Data

Diameter Health raised $18M in Series B funding led by Centene, boosting total funding to $30M.

Healthcare data company Diameter Health has raised $18M in Series B funding. The funding round was led by managed care organization Centene Corporation, with participation from existing investors Optum Ventures, LRVHealth, Connecticut Innovations and Activate Venture Partners. This brings Diameter Health’s total funding to $30 million.

Read more Digital Health Funding: Strava Raises $110M, AliveCor and Solv Closes $65M and $27M Respectively

“We are thrilled to have Centene Corporation join the Diameter Health investor syndicate in this round,” said Eric Rosow, CEO and co-founder of Diameter Health. “This new financing validates that our technology is a valuable component to solving today’s challenges of health data interoperability across an enterprise. Normalizing, enriching and integrating data across sources is time-consuming and expensive. Organizations are using our API to accelerate their own data enterprise strategy and are driving real cost efficiencies and value in closing care gaps, more accurately assessing risk, strengthening underwriting, and ultimately improving patient care and outcomes.”

Diameter synthesizes clinical data, turning it into a valuable asset for health information exchanges. Its leading FHIR-enabled integration engine, Fusion, parses, normalizes and enriches over 225 million clinical documents on behalf of health information exchanges, the Veterans Administration, state governments, large health plans, health IT vendors as well as life insurance companies, Diameter Health said in a press release.

“We invested in Diameter Health because their ability to automatically integrate and normalize clinical data will play an important role as we look to accelerate innovation and digitization across our company,” said Centene Executive Vice President and Chief Information Officer Mark Brooks.

Image: Luke Chesser, Unsplash

The investment comes at a key time of growth for Diameter Health and the U.S. healthcare market as a whole, as recent legislation outlined in the 21st Century Cures Act will accelerate increased collaboration and data sharing across the industry. The recent funding round positions the company to build on its significant momentum in the health plan and life insurance space and to advance its mission to enable data interoperability and optimization across an enterprise.

Mike Cunningham, Principal with Optum Ventures and Diameter Health board member said, “Diameter Health’s growth is accelerating in the health plan markets at impressive rates. We see the company as being fundamental in supporting the use of data across digital health transactions for healthcare organizations in the future.”

Read more From Voice-Integrated Toothbrush to Wearable Halo, 2020 Was Amazon’s Year to Explore Healthcare Space

Diameter Health plans to use the new funding to expand Fusion’s ingestion capabilities to accept all health messages, standards and data sources as well as to further enhance Fusion’s real-time enrichment and analytics with machine learning capabilities like natural language processing. Diameter Health also plans to expand its large network of direct connections between Electronic Health Record (EHR) systems, Health Information Exchanges (HIEs) and other healthcare data sources to enable more widespread, seamless and secure data exchange.

Text Link

Diameter Health Secures $18M in Series B Funding To Improve Health Data Interoperability

Healthcare data company Diameter Health has raised $18M in Series B funding. The funding round...

Healthcare data company Diameter Health has raised $18M in Series B funding. The funding round was led by managed care organization Centene Corporation, with participation from existing investors Optum Ventures, LRVHealth, Connecticut Innovations and Activate Venture Partners. This brings Diameter Health's total funding to $30 million.

Read more: Digital Health Funding: Strava Raises $110M, AliveCor and Solv Closes $65M and $27M Respectively

“We are thrilled to have Centene Corporation join the Diameter Health investor syndicate in this round,” said Eric Rosow, CEO and co-founder of Diameter Health. “This new financing validates that our technology is a valuable component to solving today's challenges of health data interoperability across an enterprise. Normalizing, enriching and integrating data across sources is time-consuming and expensive. Organizations are using our API to accelerate their own data enterprise strategy and are driving real cost efficiencies and value in closing care gaps, more accurately assessing risk, strengthening underwriting, and ultimately improving patient care and outcomes.”

Diameter synthesizes clinical data, turning it into a valuable asset for health information exchanges. Its leading FHIR-enabled integration engine, Fusion, parses, normalizes and enriches over 225 million clinical documents on behalf of health information exchanges, the Veterans Administration, state governments, large health plans, health IT vendors as well as life insurance companies, Diameter Health said in a press release.

“We invested in Diameter Health because their ability to automatically integrate and normalize clinical data will play an important role as we look to accelerate innovation and digitization across our company,” said Centene Executive Vice President and Chief Information Officer Mark Brooks.

The investment comes at a key time of growth for Diameter Health and the U.S. healthcare market as a whole, as recent legislation outlined in the 21st Century Cures Act will accelerate increased collaboration and data sharing across the industry. The recent funding round positions the company to build on its significant momentum in the health plan and life insurance space and to advance its mission to enable data interoperability and optimization across an enterprise.

Mike Cunningham, Principal with Optum Ventures and Diameter Health board member said, “Diameter Health's growth is accelerating in the health plan markets at impressive rates. We see the company as being fundamental in supporting the use of data across digital health transactions for healthcare organizations in the future.”

Read more: From Voice-Integrated Toothbrush to Wearable Halo, 2020 Was Amazon’s Year to Explore Healthcare Space

Diameter Health plans to use the new funding to expand Fusion's ingestion capabilities to accept all health messages, standards and data sources as well as to further enhance Fusion's real-time enrichment and analytics with machine learning capabilities like natural language processing. Diameter Health also plans to expand its large network of direct connections between Electronic Health Record (EHR) systems, Health Information Exchanges (HIEs) and other healthcare data sources to enable more widespread, seamless and secure data exchange.

Text Link

Bold Health Cognitive Behavior Therapy App for IBS Competes with Headspace

London-based digital health company Bold Health is developing digital therapeutics for gastro...

London-based digital health company Bold Health is developing digital therapeutics for gastrointestinal conditions. The company is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app, reports MobiHealthNews.

Researchers will be randomly assigning 300 participants with IBS to receive either Bold Health's Zemedy app or the Headspace mindfulness app for free. Each group will have the app for eight weeks, after which those who received the Headspace app will also be given access to Zemedy.

Read more: Sanofi and Babylon Team Up to Tackle Digestive Health Issues

Chronic digestive problems are common and often connected to poor mental wellbeing. Through Bold Health’s digital applications, patients get access to cognitive behavioral therapy (CBT) programs designed for their specific condition.

Zemedy’s 6-week program is designed around core cognitive behavioral therapy (CBT) principles. IBS symptoms are often exacerbated due to stress and anxiety.

The aim of the Zemedy program is to help users target symptoms and difficult emotions by changing the surrounding thoughts and behaviors. Users can practice these techniques in their own safe spaces and learn how to manage their symptoms in the long term.

After eight weeks of the trial, the researchers will administer a battery of questionnaires, and those who switched from Headspace to Zemedy will receive a third slew of questions after an additional eight weeks with Bold Health's app, the MobiHealthNews report said.

Through these surveys, the researchers will be comparing responses regarding the study's primary outcomes: IBS quality of life, and the severity of their gastrointestinal symptoms. Secondary outcomes include respondents' scores on various gastrointestinal-related measurements, including their anxiety regarding visceral gut sensations, fear of food or eating, and impairments to their work due to health conditions.

Read more: Oshi Health Launches First All-in-One Mobile App to Allow IBD Patients Manage Their Conditions

With this new trial, Bold Health is making the case that Zemedy, which is branded as a digital therapeutic, will be demonstrably more effective than a corresponding consumer wellness app.

Text Link

From Voice-Integrated Toothbrush to Wearable Halo

In 2020, Amazon expanded health services, launched a wearable, and boosted sales despite COVID-19.

For Amazon, the year 2020 was a very busy year. The company expanded its employee health offerings and launched its first wearable device.

Read more Amazon Reportedly Working on an Emotion Tracking Wearable

Amazon’s third-quarter 2020 fiscal results show that the e-commerce giant was able to increase its sales and cash flow, despite disruption due to the pandemic.

Amazon started the year by launching Amazon Care, virtual primacy care for its employees and their families living in Seattle. Amazon Care enabled patients to access care through multiple channels including texting, video chat and a mobile care clinic, where a nurse will come to the patient’s home or office. The patients are also able to get their medications to deliver via a “Care Courier” at their home or office.

2020 was also the year when the world was devastated by Coronavirus. There were several outbreaks at Amazon warehouses. In June, the company announced that it was ramping up plans to test its fulfillment center workers for coronavirus, reports MobiHealthNews.

Image: Andres Urena, Unsplash

In August, Amazon entered the wearables space by launching Amazon Halo, an on-wrist health tracker with an accompanying app. The device has a fabric band and doesn’t have a screen. The sensors track activity, temperature, and heart rate.

Amazon inked a deal with Oral-B to launch a voice-integrated toothbrush system that gives users tips on their brushing habits. The joint system includes an Oral-B electric toothbrush, an Alexa built-in smart charger base, an Oral-B brush head, and a Quick-Start guide. Besides the health focus, the Amazon built-in can play music, listen to the news and let users order more brush heads, MobiHealthNews reported.

Read more Amazon’s Halo Fitness Tracker Can Detect Your Body Fat and Tone of Voice

In November, launched a digital pharmacy, called Amazon Pharmacy, that lets customers order and manage their prescription medications online and get them delivered at home.

Text Link

Novartis Partners With App Maker Smartpatient to Help Patients

Novartis and smartpatient launch "See What's Next" on MyTherapy app to boost treatment adherence for

Novartis is partnering with German digital health company smartpatient to launch a new app feature on the MyTherapy app for patients with wet macular degeneration (AMD). Called “See What’s Next,” the new feature is designed to encourage people living with this condition to improve their treatment adherence, which is crucial to reducing the risk of vision loss.

Read more Comcast Partners with NuEyes to Help Customers with Visual Disabilities Watch TV

“Non-adherence is a challenge in most health conditions, but in few are consequences as direct and severe as in wet AMD,” says Sebastian Gaede, chief executive officer of smartpatient. “I was truly impressed seeing Novartis and us working as one team, with every single team member highly motivated by our shared goal of supporting patients in avoiding complications and reducing the risk of vision loss,” he added.

Patients are able to tap into a personalized app that will show them the tools most applicable to their needs. Ophthalmologists can provide patients with access to the system, reports MobiHealthNews.

Novartis HQ (Image credit: Andrew, via Wikimedia Commons)

Novartis initially reached out to smartpatient when it noticed a pattern of patients who would come in for one or two injections of its anti-vascular endothelial growth factor therapy treatment Beovu, but not return.

Wet AMD affects more than 20 million people worldwide, and is the leading cause of blindness in people over the age of 65 in the US, Europe, Australia, and Asia. It develops when abnormal blood vessels grow into the macula of the eye. These vessels leak blood or fluid which leads to scarring of the macula and rapid loss of central vision.

Early symptoms include distorted vision and as the disease progresses, cell damage increases, resulting in a further reduction in vision quality.

Read more Pfizer Teams Up with Popit to Improve Medication Adherence

Big pharma companies like Novartis are increasingly turning towards the digital health space to support adherence measures, drug discovery and digital therapeutics.

“See What’s Next” is currently available in Italy and Spain, with other markets to follow.

Text Link

Novartis Partners With App Maker Smartpatient to Help Patients with Wet Macular Degeneration

Novartis is partnering with German digital health company smartpatient to launch a new app...

Novartis is partnering with German digital health company smartpatient to launch a new app feature on the MyTherapy app for patients with wet macular degeneration (AMD). Called "See What’s Next," the new feature is designed to encourage people living with this condition to improve their treatment adherence, which is crucial to reducing the risk of vision loss.

Read more: Comcast Partners with NuEyes to Help Customers with Visual Disabilities Watch TV

“Non-adherence is a challenge in most health conditions, but in few are consequences as direct and severe as in wet AMD,” says Sebastian Gaede, chief executive officer of smartpatient. “I was truly impressed seeing Novartis and us working as one team, with every single team member highly motivated by our shared goal of supporting patients in avoiding complications and reducing the risk of vision loss,” he added.

Patients are able to tap into a personalized app that will show them the tools most applicable to their needs. Ophthalmologists can provide patients with access to the system, reports MobiHealthNews.

Novartis initially reached out to smartpatient when it noticed a pattern of patients who would come in for one or two injections of its anti-vascular endothelial growth factor therapy treatment Beovu, but not return.

Wet AMD affects more than 20 million people worldwide, and is the leading cause of blindness in people over the age of 65 in the US, Europe, Australia, and Asia. It develops when abnormal blood vessels grow into the macula of the eye. These vessels leak blood or fluid which leads to scarring of the macula and rapid loss of central vision.

Early symptoms include distorted vision and as the disease progresses, cell damage increases, resulting in a further reduction in vision quality.

Read more: Pfizer Teams Up with Popit to Improve Medication Adherence

Big pharma companies like Novartis are increasingly turning towards the digital health space to support adherence measures, drug discovery and digital therapeutics.

“See What’s Next” is currently available in Italy and Spain, with other markets to follow.

Text Link

From Voice-Integrated Toothbrush to Wearable Halo, 2020 Was Amazon’s Year to Explore Healthcare Space

For Amazon, the year 2020 was a very busy year. The company expanded its employee health offering...

For Amazon, the year 2020 was a very busy year. The company expanded its employee health offerings and launched its first wearable device.

Read more: Amazon Reportedly Working on an Emotion Tracking Wearable

Amazon’s third-quarter 2020 fiscal results show that the e-commerce giant was able to increase its sales and cash flow, despite disruption due to the pandemic.

Amazon started the year by launching Amazon Care, virtual primacy care for its employees and their families living in Seattle. Amazon Care enabled patients to access care through multiple channels including texting, video chat and a mobile care clinic, where a nurse will come to the patient’s home or office. The patients are also able to get their medications to deliver via a “Care Courier” at their home or office.

2020 was also the year when the world was devastated by Coronavirus. There were several outbreaks at Amazon warehouses. In June, the company announced that it was ramping up plans to test its fulfillment center workers for coronavirus, reports MobiHealthNews.

In August, Amazon entered the wearables space by launching Amazon Halo, an on-wrist health tracker with an accompanying app. The device has a fabric band and doesn’t have a screen. The sensors track activity, temperature, and heart rate.

Amazon inked a deal with Oral-B to launch a voice-integrated toothbrush system that gives users tips on their brushing habits. The joint system includes an Oral-B electric toothbrush, an Alexa built-in smart charger base, an Oral-B brush head, and a Quick-Start guide. Besides the health focus, the Amazon built-in can play music, listen to the news and let users order more brush heads, MobiHealthNews reported.

Read more: Amazon’s Halo Fitness Tracker Can Detect Your Body Fat and Tone of Voice

In November, launched a digital pharmacy, called Amazon Pharmacy, that lets customers order and manage their prescription medications online and get them delivered at home.

Text Link

Apple Watch’s Future Band Design Could Boost Battery power

Apple's new patent reveals a future Watch band with embedded batteries for extended battery life.

The U.S. Patent and Trademark Office officially granted Apple a patent for a future Apple Watch band with embedded batteries.

Read more Patent Reveals Future Apple Watches with Dazzling Designs, New Health Features and More

The new patent is named Battery Watch Band. It describes how the Apple Watch could get more battery capacity without having to increase the size of the Watch casing or find a more efficient power cell. The battery cells are sealed with the strap in order to prevent them from coming into contact with the metal casing of the watch.

“Apple’s invention covers a watch band for a future Apple Watch that houses a series of embedded batteries in order to provide additional battery life.  This can provide an additional power source for Apple Watch without increasing the size of the Apple Watch body,” reports PatentlyApple.

The watch band will be connected to the watch via pins. The watch will get recharged wirelessly through induction coils, wrapped around one of the battery elements.

Image credit: PatentlyApple

Apple Watches have fairly short battery life. For example, Apple Watch Series 6 is rated for 18 hours of use, while the Samsung Galaxy Watch 3 gets a rating for 2 days of battery life. The battery on the Fitbit Sense can last up to six days.

The future Apple Watches need longer battery life as they will be loaded with health features. The updated watchOS 7.2 will bring a new cardio fitness score that uses your VO2 max to measure your cardiorespiratory health or aerobic endurance.

Read more Apple’s Patent Suggests Smart Ring That Could Let You Control Other Devices

It may take a while for Apple to turn this new patent into reality, but some major changes on the Apple Watch 7 are on the card. It should also be noted that Apple has previously played with the idea for the band, suggesting that various sensors and batteries could be put inside each element in its Link band but Apple didn’t show us a final product.

Text Link

Apple Watch’s New Health Feature Monitors and Notifies About Your Cardio Fitness

Apple Watch's new watchOS 7.2 update introduces cardio fitness scores based on VO2 max levels.

A new feature on Apple Watch will give you a review on your fitness levels. When you update your watch’s software to watchOS 7.2, it will bring a new cardio fitness score that uses your VO2 max to measure your cardiorespiratory health, or aerobic endurance. Cardiorespiratory fitness, as measured by VO2 max, is the maximum amount of oxygen the body can use during exercise, and it can be increased through physical activity. Apple Watch already estimates average and higher levels of VO2 max during vigorous outdoor walks, runs, or hikes, which many runners and other athletes monitor to improve performance.

Read more Apple Gets FDA Clearance for its Updated Version of ECG to Detect AFib

Now, with watchOS 7, Apple Watch uses multiple sensors, including the optical heart sensor, GPS, and the accelerometer, to estimate lower levels, too. This is significant because direct measurement of VO2 max typically requires a rigorous clinical test with specialized equipment that is not readily accessible to most people. watchOS 7 also allows Apple Watch to take cardio fitness measurements as users walk throughout the day, whether or not they are tracking a workout. With this innovation, Apple Watch is better able to measure VO2 max for users with low cardio fitness, who may not complete high-intensity workouts, reports Apple.

“Cardio fitness is increasingly recognized as a powerful predictor of overall health, and with today’s update to watchOS 7, we are making it even more accessible to more people,” said Jeff Williams, Apple’s chief operating officer. “Using its advanced sensors, Apple Watch now brings estimation of low cardio fitness levels from clinics directly to a user’s wrist, so people have more insight into how they can improve their long-term health through daily activity.”

iOS 14.3 and watchOS 7.2 enable Apple Watch users to visit the Cardio Fitness category in the Health app on iPhone to review whether their cardio fitness level is classified as high, above average, below average, or low, relative to people in their same age group and of the same sex, according to data from the Fitness Registry and Importance of Exercise National Database (FRIEND).

Read more Apple Joins Forces with Researchers to Conduct Health Studies Using Apple Watch

Image: Apple

Here’s How to Set Up Cardio Fitness

  1. From the Health app on your iPhone, tap the Summary tab.
  2. Tap Set Up under Cardio Fitness, then tap Next.
  3. Confirm your details. Any changes you make here will be saved to your Health Details in Settings.
  4. Tap Next.
  5. Follow the onscreen prompts to learn about other factors that can lower your cardio fitness, as well as the cardio fitness levels for your age and sex.
  6. Tap Next.
  7. Tap Turn on Notifications to receive a notification if your Apple Watch detects that your cardio fitness level is low. You must be at least 20 years old to turn on notifications.
  8. Tap Done.
Text Link

Apple Watch’s New Health Feature Monitors and Notifies You About Your Cardio Fitness

A new feature on Apple Watch will give you a review on your fitness levels. When you update your...

A new feature on Apple Watch will give you a review on your fitness levels. When you update your watch’s software to watchOS 7.2, it will bring a new cardio fitness score that uses your VO2 max to measure your cardiorespiratory health, or aerobic endurance. Cardiorespiratory fitness, as measured by VO2 max, is the maximum amount of oxygen the body can use during exercise, and it can be increased through physical activity. Apple Watch already estimates average and higher levels of VO2 max during vigorous outdoor walks, runs, or hikes, which many runners and other athletes monitor to improve performance.

Read more: Apple Gets FDA Clearance for its Updated Version of ECG to Detect AFib

Now, with watchOS 7, Apple Watch uses multiple sensors, including the optical heart sensor, GPS, and the accelerometer, to estimate lower levels, too. This is significant because direct measurement of VO2 max typically requires a rigorous clinical test with specialized equipment that is not readily accessible to most people. watchOS 7 also allows Apple Watch to take cardio fitness measurements as users walk throughout the day, whether or not they are tracking a workout. With this innovation, Apple Watch is better able to measure VO2 max for users with low cardio fitness, who may not complete high-intensity workouts, reports Apple.

“Cardio fitness is increasingly recognized as a powerful predictor of overall health, and with today’s update to watchOS 7, we are making it even more accessible to more people,” said Jeff Williams, Apple’s chief operating officer. “Using its advanced sensors, Apple Watch now brings estimation of low cardio fitness levels from clinics directly to a user’s wrist, so people have more insight into how they can improve their long-term health through daily activity.”

iOS 14.3 and watchOS 7.2 enable Apple Watch users to visit the Cardio Fitness category in the Health app on iPhone to review whether their cardio fitness level is classified as high, above average, below average, or low, relative to people in their same age group and of the same sex, according to data from the Fitness Registry and Importance of Exercise National Database (FRIEND).

Read more: Apple Joins Forces with Researchers to Conduct Health Studies Using Apple Watch

Here's How to Set Up Cardio Fitness

  1. From the Health app on your iPhone, tap the Summary tab.
  2. Tap Set Up under Cardio Fitness, then tap Next.
  3. Confirm your details. Any changes you make here will be saved to your Health Details in Settings.
  4. Tap Next.
  5. Follow the onscreen prompts to learn about other factors that can lower your cardio fitness, as well as the cardio fitness levels for your age and sex.
  6. Tap Next.
  7. Tap Turn on Notifications to receive a notification if your Apple Watch detects that your cardio fitness level is low. You must be at least 20 years old to turn on notifications.
  8. Tap Done.

Text Link

Apple Watch’s Future Band Design Could Boost Battery Life

The U.S. Patent and Trademark Office officially granted Apple a patent for a future Apple Watch...

The U.S. Patent and Trademark Office officially granted Apple a patent for a future Apple Watch band with embedded batteries.

Read more: Patent Reveals Future Apple Watches with Dazzling Designs, New Health Features and More

The new patent is named Battery Watch Band. It describes how the Apple Watch could get more battery capacity without having to increase the size of the Watch casing or find a more efficient power cell. The battery cells are sealed with the strap in order to prevent them from coming into contact with the metal casing of the watch.

“Apple's invention covers a watch band for a future Apple Watch that houses a series of embedded batteries in order to provide additional battery life.  This can provide an additional power source for Apple Watch without increasing the size of the Apple Watch body,” reports PatentlyApple.

The watch band will be connected to the watch via pins. The watch will get recharged wirelessly through induction coils, wrapped around one of the battery elements.

Apple Watches have fairly short battery life. For example, Apple Watch Series 6 is rated for 18 hours of use, while the Samsung Galaxy Watch 3 gets a rating for 2 days of battery life. The battery on the Fitbit Sense can last up to six days.

The future Apple Watches need longer battery life as they will be loaded with health features. The updated watchOS 7.2 will bring a new cardio fitness score that uses your VO2 max to measure your cardiorespiratory health or aerobic endurance.

Read more: Apple’s Patent Suggests Smart Ring That Could Let You Control Other Devices

It may take a while for Apple to turn this new patent into reality, but some major changes on the Apple Watch 7 are on the card. It should also be noted that Apple has previously played with the idea for the band, suggesting that various sensors and batteries could be put inside each element in its Link band but Apple didn’t show us a final product.

Text Link

Combining Fitbit Wearables with Health2Sync Glucose Control App Simplifies diabetes management

Fitbit and Health2Sync improve diabetes control, reducing HbA1C and boosting activity.

Wearing Fitbit devices with Health2Sync, the number one diabetes management app in Taiwan has been clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes, according to a study was conducted with four of Taiwan’s leading diabetes clinics.

Related Fitbit and Solera Health Expand Collaboration to Reduce Type 2 Diabetes Risk

Results from the study in Taiwan revealed an improvement in patients’ health conditions, with participants recording higher levels of physical activity, reduced HbA1C, fasting blood glucose and LDL-C, and higher blood glucose measurement frequency, Fitbit said in a press release.

“We are thrilled to see such optimistic results in the clinical study. We believe that innovations in Fitbit wearable devices and Fitbit health solutions have a major role to play in the global effort against diabetes – whether it is in reducing the onset of diabetes, or helping patients to better manage their condition – and we look forward to further expanding on our partnership with Fitbit,” said Ed Deng, CEO at Health2Sync.

The Health2Sync Patient Management Platform allows healthcare providers to seamlessly monitor patients’ information and provide remote consultative advice where necessary.

The study found:

  • Average glycated hemoglobin (HbA1C) decreased 0.33%, while patients who did moderate to high-intensity activity duration of at least 150 mins per week, saw their average HbA1C decreased 0.66%
  • Average fasting blood glucose (BG) decreased 10.92 mg/dL
  • Average low-density lipoprotein cholesterol (LDL-C) decreased 11.55 mg/dL
  • Weight reduction of up to 2 kilograms among some patients
  • Increased frequency in moderate to high-intensity activity to 7.03 times a week among some patients
Each participant was given a Fitbit Inspire HR (Image: Fitbit)

Conducted over a three-month period ending in July 2020 in conjunction with the Neng-Chun Diabetes Clinic, Da-Ya Chang-An Clinic, Yier Clinic and Banqiao Da-Jun Clinic, the study, with patient consent, lets the patients’ doctors track the progress and lifestyle changes of 95 participants with T2DM. Prior to the commencement of the study, doctors at the four clinics established benchmarks for all participating patients based on blood glucose tests at the start of the trial, then on a self-monitored weekly basis throughout the study period.

Each participant was given a Fitbit Inspire HR and the participants voluntarily agreed to connect their Fitbit wearable data with the Health2Sync diabetes management app to track their progress throughout the program. Physical activity data generated from each person’s Fitbit device was integrated into the Health2Sync app, which housed other health metrics such as patients’ HbA1c, BG and cholesterol levels. This let doctors seamlessly monitor patients’ information on the Health2Sync Patient Management Platform and provide remote consultative advice where necessary.

“The results speak for themselves. We saw a reduction in some of our patients’ weight by an average of two kilograms and fasting BG levels of study participants from Da-Ya Chang-An clinic decreased 11.10 mg/dL within 3 months, leading to significant health improvements, said Dr. Kuo-Liang Lu of Da-Ya Chang-An Clinic in Taiwan.

Related UnitedHealth Group Launches New Digital Therapy To Improve Lives Of People With Type 2 Diabetes

Dr. Neng-Chu Yu of Neng-Chun Diabetes Clinic said: “Type 2 diabetes, with the right lifestyle changes – medication adherence, increased activity, and better diet – can lead to major improvements in control of blood glucose levels. The integration of Fitbit data with Health2Sync let me easily view my patients’ activities and self-monitored data, enabling me to make necessary suggestions and give guidance to help patients for further improvement.”

Text Link

May 2024: Innovation in the Fight Against Hearing Loss

Neosensory's Clarify - A breakthrough solution to improve hearing.
Text Link

April 2024: The Revolution Against Chronic Tremors

The GyroGlove revolutionizes the lives of many people suffering from tremors.
Text Link

March 2024: Revolution in Diabetes, Painless Smartpatch

Medicsen revolutionizes diabetes treatment with a painless Smartpatch.
Text Link

February 2024: Empowering Visually Impaired with GUIDI

AI Guided transforms lives with GUIDI, an advanced AI navigation companion.
Text Link

January 2024: Hydrogel-Free Flexcon® Omni-Wave™ for Biosensing

Dry electrode technology saves time and money for manufacturers while improving patient comfort!
Text Link

December 2023 : Flow Neuroscience

Flow: Home-based depression relief—fast, safe, innovative.
Text Link

November 2023: Linxens

Linxens Combines Skin Adhesive Technology and Biosensors for Cutting-Edge Medical Wearables.
Text Link

October 2023: LIFELEAF®

Discover how LIFEPLUS is reshaping health monitoring, offering real-time insights and fostering care
Text Link

September 2023: Frenz Brainband

Earable® Neuroscience´s Frenz Brainband: AI sleep & focus revolution.
Text Link

August 2023: Seismic

Seismic revolutionizes workplace safety and wellness with data-driven solutions.
Text Link

July 2023: VEMOTION

Technology that enhances early mobilization, a vital therapy in preventing adverse effects.
Text Link

June 2023: machineMD

machineMD's neurophthalmoscope: A game-changer in brain disorder detection.
Text Link

May 2023: The World's 1st Smart Wearable to Reverse Common Hair Loss

Niostem launches its hair regrowth wearable to combat pattern baldness in an Indiegogo campaign!
Text Link

April 2023: Bringing Vital Signs Monitoring into the Wearable Domain

EBV Elektronik presents key sensors for enabling vital sign sensing in wearables.
Text Link

March 2023: Implandata Ophthalmic Products GmbH

Leading the digital transformation of glaucoma care!
Text Link

February 2023: Leitwert

A Swiss-based start-up focusing on seamless device-to-cloud connectivity targeting multiple players.
Text Link

January 2023: Sony's mHealth Platform

Sony is stepping into the Wearable Market with their mSafety Platform.
Text Link

December 2022: Quad Industries

Screen-print electrodes and biosensors increase their scope of application!
Text Link

November 2022: MediBioSense Ltd.

Revolutionizing the Way Health Is Assessed, Tracked, and Treated!
Text Link

October 2022: ForgTin® by Pansatori

Giving peace to your ears by reducing Tinnitus!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.